These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 35331296)

  • 1. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy.
    Jiang Y; Zhang H; Wang J; Liu Y; Luo T; Hua H
    J Hematol Oncol; 2022 Mar; 15(1):34. PubMed ID: 35331296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular matrix (ECM) stiffness and degradation as cancer drivers.
    Najafi M; Farhood B; Mortezaee K
    J Cell Biochem; 2019 Mar; 120(3):2782-2790. PubMed ID: 30321449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix remodeling in the tumor immunity.
    Du W; Xia X; Hu F; Yu J
    Front Immunol; 2023; 14():1340634. PubMed ID: 38332915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological role of matrix stiffness in tumor growth and treatment.
    Deng B; Zhao Z; Kong W; Han C; Shen X; Zhou C
    J Transl Med; 2022 Nov; 20(1):540. PubMed ID: 36419159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.
    Gehler S; Ponik SM; Riching KM; Keely PJ
    Crit Rev Eukaryot Gene Expr; 2013; 23(2):139-57. PubMed ID: 23582036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sig1R activates extracellular matrix-induced bladder cancer cell proliferation and angiogenesis by combing β-integrin.
    Zhao F; Yang T; Zhou L; Li R; Liu J; Zhao J; Jia R
    Aging (Albany NY); 2023 May; 15(10):4182-4201. PubMed ID: 37199665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin control of tumor invasion.
    Missan DS; DiPersio M
    Crit Rev Eukaryot Gene Expr; 2012; 22(4):309-24. PubMed ID: 23272801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment.
    Niland S; Eble JA
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33379400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular matrix and its therapeutic potential for cancer treatment.
    Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
    Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy.
    Xiong J; Xiao R; Zhao J; Zhao Q; Luo M; Li F; Zhang W; Wu M
    J Transl Med; 2024 Jan; 22(1):85. PubMed ID: 38246995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies.
    Wei J; Yao J; Yan M; Xie Y; Liu P; Mao Y; Li X
    Acta Biomater; 2022 Sep; 150():34-47. PubMed ID: 35948177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effects of Matrix Biophysical Properties on Gastric Cancer Cell Behavior via Integrin-Mediated Cell-ECM Interactions.
    Xiao C; Xie N; Shu Q; Liang X; Wang Z; Wu J; Shi N; Huang X; Wei ZC; Gao X; Liu H; Wu K; Xu J; Wang JH; Liu N; Xu F
    Small; 2024 Sep; 20(36):e2309907. PubMed ID: 38712486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tension in Cancer.
    Löffek S; Franzke CW; Helfrich I
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments.
    Yuan Z; Li Y; Zhang S; Wang X; Dou H; Yu X; Zhang Z; Yang S; Xiao M
    Mol Cancer; 2023 Mar; 22(1):48. PubMed ID: 36906534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
    Lee HO; Mullins SR; Franco-Barraza J; Valianou M; Cukierman E; Cheng JD
    BMC Cancer; 2011 Jun; 11():245. PubMed ID: 21668992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy.
    Mai Z; Lin Y; Lin P; Zhao X; Cui L
    Cell Death Dis; 2024 May; 15(5):307. PubMed ID: 38693104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond matrix stiffness: targeting force-induced cancer drug resistance.
    Kalli M; Poskus MD; Stylianopoulos T; Zervantonakis IK
    Trends Cancer; 2023 Nov; 9(11):937-954. PubMed ID: 37558577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor mechanics and metabolic dysfunction.
    Tung JC; Barnes JM; Desai SR; Sistrunk C; Conklin MW; Schedin P; Eliceiri KW; Keely PJ; Seewaldt VL; Weaver VM
    Free Radic Biol Med; 2015 Feb; 79():269-80. PubMed ID: 25532934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion.
    Keely PJ
    J Mammary Gland Biol Neoplasia; 2011 Sep; 16(3):205-19. PubMed ID: 21822945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insidious changes in stromal matrix fuel cancer progression.
    Miles FL; Sikes RA
    Mol Cancer Res; 2014 Mar; 12(3):297-312. PubMed ID: 24452359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.